Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells
- PMID: 12718903
- DOI: 10.1016/s1525-0016(03)00060-1
Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells
Abstract
The ability to deliver efficiently a complete genomic DNA locus to human and rodent cells will likely find widespread application in functional genomic studies and novel gene therapy protocols. In contrast to a cDNA expression cassette, the use of a complete genomic DNA locus delivers a transgene intact with its native promoter, the exons, all the intervening introns, and the regulatory regions. The presence of flanking, noncoding genomic DNA sequences could prove critical for prolonged and appropriate gene expression. We have recently developed a technology for the rapid conversion of bacterial artificial chromosome (BAC) clones into high-capacity herpes simplex virus-based amplicon vectors. Here, we express the human low-density lipoprotein receptor (LDLR), mutated in familial hypercholesterolemia (FH), from a 135-kb BAC insert. The infectious LDLR genomic locus vectors were shown to express at physiologically appropriate levels in three contexts. First, the LDLR locus was expressed appropriately in the ldl(-/-)a7 Chinese hamster ovary (CHO) cell line immediately following infectious delivery; second, the locus was maintained within a replicating episomal vector and expressed at broadly physiological levels in CHO cells for 3 months following infectious delivery; and third, the locus was efficiently expressed in human fibroblasts derived from FH patients. Finally, we show that the infectious LDLR locus retains classical expression regulation by sterol levels in human cells. This long-term expression and physiological regulation of LDLR prepares the way for in vivo functional studies of infectious delivery of BAC inserts.
Comment in
-
One giant genomic leap for gene transfer technology.Mol Ther. 2003 May;7(5 Pt 1):571. doi: 10.1016/s1525-0016(03)00108-4. Mol Ther. 2003. PMID: 12718898 No abstract available.
Similar articles
-
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency.Nucleic Acids Res. 2007;35(15):e98. doi: 10.1093/nar/gkm570. Epub 2007 Aug 2. Nucleic Acids Res. 2007. PMID: 17675302 Free PMC article.
-
One giant genomic leap for gene transfer technology.Mol Ther. 2003 May;7(5 Pt 1):571. doi: 10.1016/s1525-0016(03)00108-4. Mol Ther. 2003. PMID: 12718898 No abstract available.
-
Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection.J Gene Med. 2007 Jun;9(6):488-97. doi: 10.1002/jgm.1041. J Gene Med. 2007. PMID: 17471590
-
Herpes simplex virus type 1 amplicon vectors for the infectious delivery and expression of genomic DNA loci.Curr Opin Mol Ther. 2005 Aug;7(4):337-45. Curr Opin Mol Ther. 2005. PMID: 16121699 Review.
-
Gene therapy for familial hypercholesterolemia.Curr Pharm Des. 2011;17(24):2575-91. doi: 10.2174/138161211797247550. Curr Pharm Des. 2011. PMID: 21774774 Review.
Cited by
-
Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin.J Virol. 2006 Apr;80(7):3293-300. doi: 10.1128/JVI.80.7.3293-3300.2006. J Virol. 2006. PMID: 16537596 Free PMC article.
-
Genetic labeling of both the axons of transduced, glutamatergic neurons in rat postrhinal cortex and their postsynaptic neurons in other neocortical areas by herpes simplex virus vectors that coexpress an axon-targeted β-galactosidase and wheat germ agglutinin from a vesicular glutamate transporter-1 promoter.Brain Res. 2010 Nov 18;1361:1-11. doi: 10.1016/j.brainres.2010.09.030. Epub 2010 Sep 16. Brain Res. 2010. PMID: 20849834 Free PMC article.
-
ICP0 inhibits the decrease of HSV amplicon-mediated transgene expression.Mol Ther. 2009 Apr;17(4):707-15. doi: 10.1038/mt.2008.306. Epub 2009 Feb 17. Mol Ther. 2009. PMID: 19223864 Free PMC article.
-
A novel human artificial chromosome gene expression system using herpes simplex virus type 1 vectors.EMBO Rep. 2006 Sep;7(9):911-8. doi: 10.1038/sj.embor.7400768. Epub 2006 Aug 11. EMBO Rep. 2006. PMID: 16906131 Free PMC article.
-
Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts.J Gen Virol. 2009 Sep;90(Pt 9):2209-20. doi: 10.1099/vir.0.012203-0. Epub 2009 Jun 10. J Gen Virol. 2009. PMID: 19515829 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous